Pyrrolidine-constrained phenethylamines: The design of potent, selective, and pharmacologically efficacious dipeptidyl peptidase IV (DPP4) inhibitors from a lead-like screening hit

References

Page 1

	Year	Citations
Effect of 6-week course of glucagon-like peptide 1 on glycaemic control, insulin sensitivity, and β-cell function in type 2 diabetes: a parallel-group study Mette Zander, Sten Madsbad, Jan Lysgaard Madsen, The Lancet Metabolic SyndromeDiabetes ManagementGlucagon-like Peptide 1DiabetesPhysiology	2002	1.3K
Degradation of glucose-dependent insulinotropic polypeptide and truncated glucagon-like peptide 1 in vitro and in vivo by dipeptidyl peptidase IV. Timothy J. Kieffer, Christopher H.S. McIntosh, Raymond A. Pederson Endocrinology GlycobiologyPeptide SciencePeptide ChemistryInsulin SignalingIncubation Mixture	1995	1.1K
(2<i>R</i>)-4-Oxo-4-[3-(Trifluoromethyl)-5,6-dihydro[1,2,4]triazolo[4,3-<i>a</i>]pyrazin- 7(8<i>H</i>)-yl]-1-(2,4,5-trifluorophenyl)butan-2-amine: A Potent, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes Dooseop Kim, Liping Wang, Maria Beconi, Journal of Medicinal Chemistry	2004	808
Is There a Difference between Leads and Drugs? A Historical Perspective Tudor I. Oprea, A. M. Davis, Simon J. Teague, Journal of Chemical Information and Computer Sciences	2001	771
Both subcutaneously and intravenously administered glucagon-like peptide I are rapidly degraded from the NH2-terminus in type II diabetic patients and in healthy subjects Carolyn F. Deacon, Michael A. Nauck, M. Toft-Nielsen, Diabetes Diabetes ManagementHealthy SubjectsBiochemistryMedicineInsulin Management	1995	716
Inhibition of Dipeptidyl Peptidase-4 Reduces Glycemia, Sustains Insulin Levels, and Reduces Glucagon Levels in Type 2 Diabetes Bo Åhrén, Mona Landin‐Olsson, Per‐Anders Jansson, The Journal of Clinical Endocrinology & Metabolism Glucagon ResponsesGlycobiologyInsulin SignalingGastrointestinal Peptide HormoneMetabolic Syndrome	2004	711
Truncated GLP-1 (proglucagon 78?107-amide) inhibits gastric and pancreatic functions in man A. Wettergren, Birgit Schjoldager, Poul Erik Mortensen, Digestive Diseases and Sciences Pancreatic FunctionsPancreatic CancerMedicineDiabetesPhysiology	1993	668
Discovery and Preclinical Profile of Saxagliptin (BMS-477118): A Highly Potent, Long-Acting, Orally Active Dipeptidyl Peptidase IV Inhibitor for the Treatment of Type 2 Diabetes David J. Augeri, Jeffrey A. Robl, David A. Betebenner, Journal of Medicinal Chemistry	2005	617
1-[[(3-Hydroxy-1-adamantyl)amino]acetyl]-2-cyano-(<i>S</i>)-pyrrolidine: A Potent, Selective, and Orally Bioavailable Dipeptidyl Peptidase IV Inhibitor with Antihyperglycemic Properties Edwin B. Villhauer, J. A. Brinkman, Goli B. Naderi, Journal of Medicinal Chemistry Molecular PharmacologyMedicinal ChemistryPharmaceutical ScienceSelective Dpp-iv InhibitorBiochemistry	2003	609
Molecular cloning of fibroblast activation protein alpha, a member of the serine protease family selectively expressed in stromal fibroblasts of epithelial cancers. Matthew J. Scanlan, B.K. Mohan Raj, Benjamin F. Calvo, Proceedings of the National Academy of Sciences Fap AlphaSerine Protease FamilyImmunologyExpression CloningPathology	1994	549

Page 1